Published On: September 30, 201910MD announces election of new Board of Directors
The shareholders of 10MD have elected Mrs Pernilla Linden and Mr Mats Alm as directors of the Board in order to strengthen and prepare the company for the market launch of HeadPeace and MindPeace.
Published On: September 10, 2019Successful verification of MindPeace in Europe
Experienced doctors acknowledged the added value of MindPeace - a new 10MD product, which expands 10MD's portfolio of products based on TeXray.
Published On: July 10, 2019Decision to grant 10MD patent in Europe
10MD is delighted to announce that a Decision to Grant has been received from the European Patent Agency regarding the patent EP 2.981.975 and that national publications shall be assigned shortly.
Published On: June 24, 2019CE mark applications submitted to regulatory authorities
HeadPeace will soon be accompanied by three additional products in the 10MD product portfolio based on the world's first radiation protection textile, TeXray.
Published On: June 18, 201910MD continues to build Intellectual properties
10MD has recently filed another patent application for the company's next product line. The patent family constitutes an innovative product line focusing on the reduction of radiation exposure for doctors, nurses and technicians throughout the global market.
Published On: June 18, 2019Final grant for 10MD platform patent
Concluding the round of approvals with the Japanese patent authorities, 10MD can now summarize the geographical protection of its core radiation protection material, TeXray. The patent has already been approved in USA, Europe, Russia, Australia and Sweden.
